MFA
AMPE

Mayflower Financial Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Mayflower Financial Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-80
Closed -$1K – 369
2022
Q3 		$1K Hold
80
– – ﹤0.01% 339
2022
Q2 		$4K Hold
80
– – ﹤0.01% 336
2022
Q1 		$11K Hold
80
– – ﹤0.01% 362
2021
Q4 		$14K Hold
80
– – ﹤0.01% 350
2021
Q3 		$39K Hold
80
– – 0.01% 329
2021
Q2 		$40K Hold
80
– – 0.01% 315
2021
Q1 		$41K Hold
80
– – 0.01% 290
2020
Q4 		$38K Buy
+80
New +$26.2K 0.01% 277

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Mayflower Financial Advisors's AMPE Position: Q4 2022 in Review

Mayflower Financial Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 80 shares — an estimated $1K sold.

Mayflower Financial Advisors first reported a position in AMPE in Q4 2020 and held it in 8 quarters. The position peaked at $41K in Q1 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Mayflower Financial Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Mayflower Financial Advisors sold 80 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $1K.
  • Mayflower Financial Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q4 2020 and held it in 8 quarters.
  • Mayflower Financial Advisors's Ampio Pharmaceuticals Inc. position peaked at $41K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Mayflower Financial Advisors's 13F filing for Q4 2022, filed 19 Jan 2023.